| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.51B | $4.58B | $4.55B | $4.51B | $3.96B |
| Cost of Revenue | $3.01B | $3.03B | $2.98B | $3.01B | $2.62B |
| Gross Profit | $1.50B | $1.55B | $1.58B | $1.50B | $1.34B |
| Operating Expenses | – | – | – | – | – |
| R&D | $162.30M | $173.10M | $173.90M | $155.60M | $141.00M |
| SG&A | $1.01B | $1.02B | $995.60M | $928.93M | $820.21M |
| Operating Income | $409.90M | $533.30M | $430.70M | $575.66M | $518.28M |
| Interest Expense | – | – | $58.70M | $35.74M | $28.66M |
| Tax Expense | $61.50M | $93.90M | $70.80M | $109.20M | $89.94M |
| Net Income | $316.10M | $418.90M | $329.70M | $443.34M | $409.88M |
| EPS (basic) | 3.1800 | 4.0400 | 3.1600 | 4.2300 | 3.8200 |
| EPS (diluted) | 3.1700 | 4.0100 | 3.1300 | 4.2000 | 3.7800 |
| Shares (diluted) | $99.80M | $104.40M | $105.30M | $105.65M | $108.47M |